Jeanelle Kam, MD

Jeanelle Kam, MD, is a trained OB/GYN with more than a decade of CRU drug development experience across multiple indications. As a CPI and Medical Director at the Phase I Dallas CRU, Dr.

Isagani (Gani) M. Chico, MD

Isagani (Gani) M. Chico, MD, is Vice President and Global Head for Oncology Therapeutic Expertise, Fortrea Clinical Development Services, based in Baltimore, Maryland.

Isabella Presch, MD, MBA

Isabella Presch, MD, MBA, is a Senior Medical Director. She is a certified pediatric surgeon with more than 10 years of clinical experience across therapeutic areas in academia as well as private and public hospitals.

Ines Pagel-Langenickel, MD

Ines Pagel-Langenickel, MD, is an Executive Medical Director of CVMER (cardiovascular, metabolic, endocrine and renal) at Fortrea.

Hannah Simonds

Hannah has more than 12 years industry experience focused on healthcare communications, patient insights and input, recruitment and retention solutions and patient support programs.

Gong Qing, MD

Gong Qing, MD, is Associate Medical Director for Fortrea Clinical Development Services, based in Shanghai, China.

George Vamvakias

• 33 years in industry with experience in pharmaceutical and medical device product development 
• 28 years in Project Management roles 
• Career spans both CRO and Pharma/Biologics/Med Device roles 
• Project M

Friedrich Wieser, MD

Friedrich (Fritz) Wieser, MD, is an OB/GYN who received his MD from the Vienna Medical University (Vienna, Austria). After completing his gynecology residency at the Dept.

Frederick Derosier, DO

Frederick Derosier, DO, is Fortrea’s Vice President for Rare Diseases, Advanced Therapies, and Pediatrics and additionally serves as Therapeutic Strategy Lead for Cell and Gene Therapies. Dr.

Franklin Gaylis, MD, FACS

Franklin Gaylis, MD, FACS, is a Urology Consultant at Fortrea.